Calliditas Therapeutics IPO Presentation Deck
Board of directors
ELMAR SCHNEE
Chairman
Selected experience:
Previously CEO of Merck Serono and
instrumental in the acquisition of Serono by
Merck KGaA. He has also served as General
Partner and member of the Executive Board
of Merck KGaA and held several senior global
management positions with UCB and Sanofi
BENGT JULANDER
Board member
Selected experience:
Member of the Boards of Bringwell, Linc,
Livland Skog, Medivir, Proequo, Sedana
Medical, Stille and Swevet, and a number of
smaller companies
calliditas
HILDE FURBERG
Board member
Selected experience:
Currently Senior VP of Rare Disease EMEA at
Sanofi Genzyme and Non-executive Director at
BerGenBio. Previously, held board
memberships at Algeta, Clavis Pharma and
Probi
DIANE PARKS
Board member
Selected experience:
Deep sales and marketing experience from
the US; has held positions such as Head of
U.S. Commercial for Kite Pharma, VP of Sales
for Amgen and Head of Global Marketing at
Pharmacyclics
LENNART HANSSON
Board member
Selected experience:
Currently Senior Advisor at industrifonden.
Previously executive positions at KabiGen,
Symbicom, AstraZeneca and Biovitrum
THOMAS EKLUND
Board member
Selected experience:
Chairman of the Board of Moberg Pharma and
Itrim. Board member of multiple companies
incl. Boule Diagnostics and Biotage. Senior
positions at Investor Growth Capital, Alfred
Berg and Handelsbanken
June 2020
37View entire presentation